The 4th Annual European Statistical Forum (ESF) is taking place on Monday, 18th of November in Amsterdam, the Netherlands. Kubo Recruitment is sponsoring this event which discusses the pressing issues of biostatistics in the pharmaceutical, biotech and clinical trials environment.
The topic of this year's forum is "Missing Data in Clinical Trials".
The handling of missing data in clinical trials has become a crucial topic for clinical drug development, in particularly with respect to the regulatory process. New methodologies and techniques have emerged such as mixed-model repeated measures, multiple imputations, pattern-mixture models for longitudinal data as well as specific censoring rules and models for time to event data.
The ESF 2013 is dedicated to the investigation, exploration as well as handling and analysis of missing data in clinical trials by presenting:
- State-of-the-art statistical methodology
- Case studies from clinical trials showing how missing data can be handled and how they can impact trial results
- Regulatory viewpoints on this topic
- Case studies from clinical trials showing how missing data can be handled and how they can impact trial results
- Regulatory viewpoints on this topic
The ESF Scientific Board includes: Jens-Otto Andreas, Director Global Biostatistics EU Group for UCB Biosciences GmbH, Lisa Comarella, Director, Biostatistics and Senior Project Manager for CROS NT, Frank Fleischer, Global BCA at Boehringer Ingelheim Pharma GmbH & Co. KB, and Giacomo Mordenti, Senior Director Compound Development & Branding-Head Biostatistics at Grünenthal.
The conference agenda promises a list of prominent speakers from some of Europe's top pharma and biotech companies.
Details:
European Statistical Forum
Monday, 18th of November 2013; 09:00 - 17.30
NH Amsterdam Centre
Stadhouderskade 7, Amsterdam, The Netherlands
Monday, 18th of November 2013; 09:00 - 17.30
NH Amsterdam Centre
Stadhouderskade 7, Amsterdam, The Netherlands
No comments:
Post a Comment